These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9048344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal myogenic constriction protects the kidney from age-related hypertensive renal damage in the Fawn-Hooded rat.
    Vavrinec P, Henning RH, Goris M, Landheer SW, Buikema H, van Dokkum RP.
    J Hypertens; 2013 Aug; 31(8):1637-45. PubMed ID: 23811996
    [Abstract] [Full Text] [Related]

  • 4. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.
    Srp Arh Celok Lek; 2002 Aug; 130(3-4):73-80. PubMed ID: 12154518
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of glomerular injury in the fawn-hooded rat: early glomerular capillary hypertension predicts glomerular sclerosis.
    Simons JL, Provoost AP, Anderson S, Troy JL, Rennke HG, Sandstrom DJ, Brenner BM.
    J Am Soc Nephrol; 1993 May; 3(11):1775-82. PubMed ID: 8329672
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure and the susceptibility to renal damage after unilateral nephrectomy and L-NAME-induced hypertension in rats.
    van Dokkum RP, Jacob HJ, Provoost AP.
    Nephrol Dial Transplant; 2000 Sep; 15(9):1337-43. PubMed ID: 10978388
    [Abstract] [Full Text] [Related]

  • 7. Tubuloglomerular feedback and prolonged ACE-inhibitor treatment in the hypertensive fawn-hooded rat.
    Verseput GH, Braam B, Provoost AP, Koomans HA.
    Nephrol Dial Transplant; 1998 Apr; 13(4):893-9. PubMed ID: 9568846
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of glomerular injury in the fawn-hooded rat: effect of unilateral nephrectomy.
    Simons JL, Provoost AP, De Keijzer MH, Anderson S, Rennke HG, Brenner BM.
    J Am Soc Nephrol; 1993 Dec; 4(6):1362-70. PubMed ID: 8130363
    [Abstract] [Full Text] [Related]

  • 9. A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats.
    Koeners MP, Braam B, van der Giezen DM, Goldschmeding R, Joles JA.
    Am J Physiol Regul Integr Comp Physiol; 2008 Jun; 294(6):R1847-55. PubMed ID: 18417652
    [Abstract] [Full Text] [Related]

  • 10. The effect of a converting enzyme inhibitor upon renal damage in spontaneously hypertensive Fawn Hooded rats.
    Westenend PJ, Nooyen YA, van der Krogt JA, van Brummelen P, Weening JJ.
    J Hypertens; 1992 May; 10(5):417-22. PubMed ID: 1317901
    [Abstract] [Full Text] [Related]

  • 11. Progression of hypertension and kidney disease in aging fawn-hooded rats is mediated by enhanced influence of renin-angiotensin system and suppression of nitric oxide system and epoxyeicosanoids.
    Doleželová Š, Jíchová Š, Husková Z, Vojtíšková A, Kujal P, Hošková L, Kautzner J, Sadowski J, Červenka L, Kopkan L.
    Clin Exp Hypertens; 2016 May; 38(7):644-651. PubMed ID: 27669111
    [Abstract] [Full Text] [Related]

  • 12. Significant suppressive effect of low-dose temocapril, an ACE inhibitor with biliary excretion, on FGS lesions in hypertensive rats.
    Suyama K, Muso E, Yashiro M, Sasayama S.
    Nephron; 2000 Dec; 86(4):491-8. PubMed ID: 11124599
    [Abstract] [Full Text] [Related]

  • 13. Hyperlipidemia is secondary to proteinuria and is completely normalized by angiotensin-converting enzyme inhibition in hypertensive fawn-hooded rats.
    Verseput GH, Provoost AP, van Tol A, Koomans HA, Joles JA.
    Nephron; 1997 Dec; 77(3):346-52. PubMed ID: 9375831
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage.
    Bomback AS, Muskala P, Bald E, Chwatko G, Nowicki M.
    Clin Nephrol; 2009 Dec; 72(6):449-56. PubMed ID: 19954722
    [Abstract] [Full Text] [Related]

  • 18. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure.
    Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS.
    Kidney Int Suppl; 1996 Dec; 57():S132-6. PubMed ID: 8941934
    [Abstract] [Full Text] [Related]

  • 19. The role of intraglomerular pressure in the initiation and progression of renal disease.
    Anderson S, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176
    [Abstract] [Full Text] [Related]

  • 20. ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats.
    Ono H, Ono Y, Frohlich ED.
    Hypertension; 1996 Feb; 27(2):176-83. PubMed ID: 8567038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.